iFAST – impedance-based Fast AST

A novel phenotypic technology, which takes 2 mins to monitor the tiny electrical changes taking place in sensitive bacteria treated with antibiotics.

Fast, cheap, phenotypic, small technology that fits seamlessly into a diagnostic laboratory workflow to speed up UTI and other AST from 48hrs to 3hrs.

  • Antimicrobial stewardship
  • Microbial diagnostics
  • Antimicrobial compound/strategy
  • Infection prevention
  • Removal antibiotics/bacteria

  • Bacteria
  • Viruses
  • Fungi
  • Yeasts
  • Parasites

  • Human
  • Veterinary
  • Other
  • AgriFood
  • Environmental

Development stage:
  • Research
  • Development
  • Validation
  • Market entry
  • Marketed product

  • Government
  • Company
  • Academia
  • Institute
  • NGO

  • Co-develop
  • Joint Venture
  • License
  • Outsource
  • Sell

Funding organisation:
  • CARB-X
  • FIND
  • OTHER / NA

Infectious disease area:
  • UTI
  • STI
  • BSI
  • RTI
  • GII
  • SSTI
  • CNSI
  • IAI
  • SSI

Geographic origin:
  • Eurasia
  • North America
  • South America
  • Africa
  • Oceania

Partners with expertise in development of diagnostic platforms for clinical use or interested in incorporating the technology in antibiotic discovery and evaluation programmes

UKHSA is an executive agency of the Department of Health. UKHSA Porton specialises in R&D incl. new antimicrobial therapies, vaccines & diagnostics.

Applications: AST for UTI, MRSA, N. gonorrhoeae; characterisation of bacteriophage infection & host susceptibility; research tool to investigate modes of action, mechanism of resistance etc. As read-out takes 2mins, immediate changes can be seen.

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed